Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antoine Guillon

Showing results (51-60 of 104) with videos related to

Pageof 11
Sort By:
Annals of Intensive Care|May 4, 2018
Data-driving methods: More than merely trendy buzzwords?Julien Textoris, Fabio Silvio Taccone, Lara Zafrani, et al.
Annals of Intensive Care|June 12, 2019
Preclinical septic shock research: why we need an animal ICUAntoine Guillon, Sebastien Preau, Jérôme Aboab, et al.
European Journal of Hospital Pharmacy : Science and Practice|March 23, 2025
Physicochemical stability of a polysorbate-80-containing solvent compounded in the hospital pharmacy and used to reconstitute a biologic for nebulisationLaura Négrier, Marine Roche, Damien Lannoy, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 12, 2023
The proteolytic airway environment associated with pneumonia acts as a barrier for treatment with anti-infective antibodiesTimothée Blin, Christelle Parent, Gabrielle Pichon, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|December 28, 2018
Salbutamol Nebulization During Noninvasive Ventilation in Exacerbated Chronic Obstructive Pulmonary Disease Patients: A Randomized Controlled TrialLaetitia Bodet-Contentin, Antoine Guillon, Thierry Boulain, et al.
Cytokine|November 1, 2018
Inactivation of the interleukin-22 pathway in the airways of cystic fibrosis patientsAntoine Guillon, Deborah Brea, Emilie Luczka, et al.
ERJ Open Research|May 20, 2025
A comprehensive evaluation of murine and human <i>ex vivo</i> cultured alveolar macrophagesCamille David, Deborah Brea, Charles Verney, et al.
Pulmonary Pharmacology & Therapeutics|May 19, 2019
Intra-tracheal amikacin spray delivery in healthy mechanically ventilated pigletsAntoine Guillon, François Darrouzain, Nathalie Heuzé-Vourc'h, et al.
Critical Care (London, England)|September 2, 2023
Long-term immunosuppressive treatment is not associated with worse outcome in patients hospitalized in the intensive care unit for septic shock: the PACIFIC studyJulien Vaidie, Edwige Peju, Louise-Marie Jandeaux, et al.
Virulence|October 30, 2016
Pseudomonas aeruginosa proteolytically alters the interleukin 22-dependent lung mucosal defenseAntoine Guillon, Deborah Brea, Eric Morello, et al.
Pageof 11

Showing results (51-60 of 104) with videos related to

Sort By:
Pageof 11
Annals of Intensive Care|May 4, 2018
Data-driving methods: More than merely trendy buzzwords?Julien Textoris, Fabio Silvio Taccone, Lara Zafrani, et al.
Annals of Intensive Care|June 12, 2019
Preclinical septic shock research: why we need an animal ICUAntoine Guillon, Sebastien Preau, Jérôme Aboab, et al.
European Journal of Hospital Pharmacy : Science and Practice|March 23, 2025
Physicochemical stability of a polysorbate-80-containing solvent compounded in the hospital pharmacy and used to reconstitute a biologic for nebulisationLaura Négrier, Marine Roche, Damien Lannoy, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 12, 2023
The proteolytic airway environment associated with pneumonia acts as a barrier for treatment with anti-infective antibodiesTimothée Blin, Christelle Parent, Gabrielle Pichon, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|December 28, 2018
Salbutamol Nebulization During Noninvasive Ventilation in Exacerbated Chronic Obstructive Pulmonary Disease Patients: A Randomized Controlled TrialLaetitia Bodet-Contentin, Antoine Guillon, Thierry Boulain, et al.
Cytokine|November 1, 2018
Inactivation of the interleukin-22 pathway in the airways of cystic fibrosis patientsAntoine Guillon, Deborah Brea, Emilie Luczka, et al.
ERJ Open Research|May 20, 2025
A comprehensive evaluation of murine and human <i>ex vivo</i> cultured alveolar macrophagesCamille David, Deborah Brea, Charles Verney, et al.
Pulmonary Pharmacology & Therapeutics|May 19, 2019
Intra-tracheal amikacin spray delivery in healthy mechanically ventilated pigletsAntoine Guillon, François Darrouzain, Nathalie Heuzé-Vourc'h, et al.
Critical Care (London, England)|September 2, 2023
Long-term immunosuppressive treatment is not associated with worse outcome in patients hospitalized in the intensive care unit for septic shock: the PACIFIC studyJulien Vaidie, Edwige Peju, Louise-Marie Jandeaux, et al.
Virulence|October 30, 2016
Pseudomonas aeruginosa proteolytically alters the interleukin 22-dependent lung mucosal defenseAntoine Guillon, Deborah Brea, Eric Morello, et al.
Pageof 11